Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-05-31
2011-05-31
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S200000
Reexamination Certificate
active
07951793
ABSTRACT:
Compounds are provided which have the structurewhereinZ1is (CH2)qor C═O;Z2is (CH2)por C═O;D is —CH═ or C═O or (CH2)mwhere m is0, 1, 2or3;n=0, 1or2; p=1or2; q=0, 1or2;Q is C or N;X is CH or N;X2is C, N, O or S;X3is C, N, O or S;X4is C, N, O or S;X5is C, N, O or S;X6is C, N, O or S;provided that at least one of X2, X3, X4X5and X6is N; and at least one of X2, X3, X4X5and X6is C; andA, B, R1, R2, R2a, R4, R3, E, Z and Y are as defined herein, which compounds are useful in treating diabetes and related diseases.
REFERENCES:
patent: 5846966 (1998-12-01), Rosenblum et al.
patent: 6143718 (2000-11-01), Kolterman et al.
patent: 6306887 (2001-10-01), Chupak et al.
patent: 6414002 (2002-07-01), Cheng et al.
patent: 0 520 723 (1994-06-01), None
patent: 1 067 109 (2001-01-01), None
patent: A-2001-226350 (2001-08-01), None
patent: WO 92/22533 (1992-12-01), None
patent: WO 95/18130 (1995-07-01), None
patent: WO 96/38415 (1996-12-01), None
patent: WO 97/00258 (1997-01-01), None
patent: WO 97/27847 (1997-08-01), None
patent: WO 97/27857 (1997-08-01), None
patent: WO 97/28137 (1997-08-01), None
patent: WO 97/28149 (1997-08-01), None
patent: WO 97/31907 (1997-09-01), None
patent: WO 98/00137 (1998-01-01), None
patent: WO 98/00403 (1998-01-01), None
patent: WO 98/27974 (1998-07-01), None
patent: WO 99/07357 (1999-02-01), None
patent: WO 99/08501 (1999-02-01), None
patent: WO 99/11255 (1999-03-01), None
patent: WO 99/15520 (1999-04-01), None
patent: WO 99/16758 (1999-04-01), None
patent: WO 99/16770 (1999-04-01), None
patent: WO 99/20275 (1999-04-01), None
patent: WO 99/46232 (1999-09-01), None
patent: WO 00/08002 (2000-02-01), None
patent: WO 00/64876 (2000-11-01), None
patent: WO 00/64888 (2000-11-01), None
patent: WO 01/21602 (2001-03-01), None
patent: WO 01/38325 (2001-05-01), None
patent: WO 02/096357 (2002-12-01), None
Wolff et. al., “Burger's Medicinal Chemistry and Drug Discovery,” 5th Ed. Part 1, pp. 975-977 (1995).
Banker, et. al., Modern Pharmaceuticals, 2002; p. 596.
Cobb, J.E. et al., “N-(2-Benzoylphenyl)-L-tyrosine PPARγAgonists. 3. Structure-Activity Relationship and Optimization of theN-Aryl Substituent”, J. Med. Chem., vol. 41, pp. 5055-5069 (1998).
Collins, J.L. et al., “N-(2-Benzoylphenyl)-L-tyrosine PPARγAgonists. 2. Structure-Activity Relationship and Optimization of the Phenyl Alkyl Ether Moiety”, J. Med. Chem., vol. 41, pp. 5037-5054 (1998).
Henke, B.R. et al., “N-(2-Benzoylphenyl)-L-tyrosine PPARγAgonists. 1, Discovery of a Novel Series of Potent Antihyperglycemic and Antihyperlipidemic Agents”, J. Med. Chem., vol. 41, pp. 5020-5036 (1998).
Chen Sean
Cheng Peter T. W.
Devasthale Pratik
Ding Charles Z.
Herpin Timothy F.
Bristol--Myers Squibb Company
Jarrell Noble
Rodney Burton
Wilson James O
LandOfFree
Substituted heterocyclic derivatives useful as antidiabetic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted heterocyclic derivatives useful as antidiabetic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted heterocyclic derivatives useful as antidiabetic... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2699480